FORWARD-LOOKING STATEMENTS WARNING

This document contains certain forward-looking statements. Forward-looking statements are statements that are not of historical nature. You can identify these statements by the use of forward-looking terminology such as "believe," "estimate," "forecast," "plan," "project," "expect," "intend," "may," "will," "should," or other similar terms. Additionally, forward-looking statements may relate to strategies, plans, business prospects, goals, future events, or intentions. These forward-looking statements can be found in various sections of this document and include, among other things, statements regarding our intentions, beliefs, or current expectations regarding the DEXNET business model, development costs, liquidity, growth prospects, strategies, and expectations for cryptocurrency market development and blockchain technology.

By their nature, forward-looking statements involve risks and uncertainties as they are related to future events and circumstances. We strongly recommend that you carefully review this document, especially the "Risk Factors" section, to gain a full understanding of the risks associated with acquiring DEXNET products or services. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee actual results. Many factors discussed in this document, some of which are beyond our control, are crucial to determining the future success of DEXNET and whether it will be launched in line with our current expectations. Ultimately, actual results may differ significantly from what could be expected based on forward-looking statements. Due to these and other uncertainties, you should not interpret the inclusion of forward-looking statements in this document as a commitment by DEXNET (or any other organization created for the development of DEXNET) that its plans and objectives will be achieved, and you should not unreasonably rely on these forward-looking statements. We commit to update forward-looking statements only as required by law.

Important Notices

This informational document is intended to provide specific information related to the purchase of products or services associated with DEXNET tokens and should be used exclusively in connection with these tokens.

Please note that this document is provided to you on the assumption that you have a lawful right to possess it or access it in accordance with the laws of your jurisdiction.

You are prohibited from transmitting this document to any person in any jurisdiction where it would be unlawful.

This document does not constitute any form of offer and unequivocally does not represent an initial public offering or any other offer of shares or ownership stakes.

Ownership of any token associated with DEXNET does not confer ownership rights, shares, or equity in DEXNET and does not entitle you to receive dividends.

When making decisions, potential buyers should rely on their personal assessment of the DEXNET business model and the tokens issued by DEXNET, considering both their advantages and risks. Potential buyers should not interpret the content of this document as legal, business, tax, accounting, investment, financial, or other recommendations. We urge each potential buyer to consult with their advisors regarding legal, business, tax, regulatory, accounting, financial, and other consequences.

ACTIONS BY CLIENTS RELATED TO DEXNET TOKENS CREATE RISKS AND MAY LEAD TO LOSS OR A REDUCTION IN THE VALUE OF PRODUCTS OR SERVICES.

NOTHING IN THIS DOCUMENT CONSTITUTES AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION.

NEITHER DEXNET TOKENS NOR SAFT (OR SIMILAR) AGREEMENTS INCLUDED IN THIS AGREEMENT HAVE BEEN APPROVED BY THE U.S. SECURITIES AND EXCHANGE COMMISSION ("SEC") OR ANY OTHER REGULATORY AUTHORITY GOVERNING SECURITIES. NEITHER THE SEC NOR ANY OTHER REGULATORY BODY HAS REVIEWED THE INFORMATION PROVIDED IN THIS DOCUMENT FOR ACCURACY OR COMPLETENESS.

THE ISSUANCE OF DEXNET TOKENS HAS NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933 (THE "SECURITIES ACT") OR ANY OTHER APPLICABLE SECURITIES LAW, AND DEXNET TOKENS CANNOT BE OFFERED, SOLD, OR OTHERWISE TRANSFERRED IN THE UNITED STATES OR TO THE ACCOUNT OF ANY PERSON IN THE UNITED STATES UNLESS SUCH TRANSACTION IS EXEMPT UNDER THE SECURITIES ACT OR ANY OTHER APPLICABLE SECURITIES LAWS.

We reserve the right to prepare additional documents and materials (regardless of their name) for registration or reliance on any available exemption from registration requirements under the U.S. Securities Act or securities laws of any other jurisdiction for the purpose of offering and selling DEXNET tokens in the United States or other jurisdictions during the sale of DEXNET tokens (as provided in this document).

DEXNET TOKENS AND/OR ANY SAFT (OR SIMILAR) AGREEMENTS RELATED THERETO WILL BE SUBJECT TO RESTRICTIONS ON TRANSFER AND RESALE IN ACCORDANCE WITH APPLICABLE U.S. SECURITIES LAWS AND/OR OTHER APPLICABLE LAWS WHEN TRANSFERRED OR RESOLD.